Castlight Health, inc. (NYSE:CSLT) CFO Mangini Siobhan Nolan sold 8,866 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $3.70, for a total transaction of $32,804.20. Following the completion of the transaction, the chief financial officer now directly owns 78,561 shares of the company’s stock, valued at $290,675.70. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of Castlight Health, inc. (CSLT) opened at $3.75 on Monday. Castlight Health, inc. has a 12 month low of $3.05 and a 12 month high of $5.50. The company has a quick ratio of 1.94, a current ratio of 1.94 and a debt-to-equity ratio of 0.03.

Castlight Health, inc. (NYSE:CSLT) last released its quarterly earnings data on Wednesday, October 25th. The software maker reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.02. The firm had revenue of $34.60 million for the quarter, compared to analyst estimates of $34.61 million. Castlight Health, inc. had a negative net margin of 45.14% and a negative return on equity of 32.57%. Castlight Health, inc.’s quarterly revenue was up 35.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.05) earnings per share. equities analysts expect that Castlight Health, inc. will post -0.43 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/11/20/insider-selling-castlight-health-inc-cslt-cfo-sells-32804-20-in-stock.html.

Large investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in shares of Castlight Health, inc. by 7.6% in the first quarter. Vanguard Group Inc. now owns 2,673,760 shares of the software maker’s stock valued at $9,760,000 after purchasing an additional 189,359 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Castlight Health, inc. by 52.9% in the second quarter. Bank of New York Mellon Corp now owns 222,660 shares of the software maker’s stock valued at $924,000 after purchasing an additional 77,011 shares during the period. Wilbanks Smith & Thomas Asset Management LLC acquired a new stake in shares of Castlight Health, inc. in the second quarter valued at approximately $264,000. Schwab Charles Investment Management Inc. increased its stake in shares of Castlight Health, inc. by 25.5% in the second quarter. Schwab Charles Investment Management Inc. now owns 249,281 shares of the software maker’s stock valued at $1,035,000 after purchasing an additional 50,687 shares during the period. Finally, FMR LLC increased its stake in shares of Castlight Health, inc. by 49.2% in the second quarter. FMR LLC now owns 11,433,928 shares of the software maker’s stock valued at $47,451,000 after purchasing an additional 3,768,009 shares during the period. Institutional investors own 41.67% of the company’s stock.

A number of equities analysts have weighed in on CSLT shares. Canaccord Genuity raised shares of Castlight Health, inc. from a “hold” rating to a “buy” rating in a research report on Tuesday, October 10th. Zacks Investment Research raised shares of Castlight Health, inc. from a “hold” rating to a “buy” rating and set a $4.50 price objective for the company in a research report on Monday, October 30th. BidaskClub raised shares of Castlight Health, inc. from a “strong sell” rating to a “sell” rating in a research report on Wednesday, September 13th. ValuEngine cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research report on Thursday, August 10th. Finally, Chardan Capital decreased their price objective on shares of Castlight Health, inc. from $6.50 to $6.30 and set a “buy” rating for the company in a research report on Thursday, October 26th. Three analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $5.22.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Stock Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related stocks with our FREE daily email newsletter.